ELF is not a good buy right now for a Beginner investor focused on long-term holding. The business is still growing strongly, but the stock’s trend is weak, analyst targets are falling, insiders are selling heavily, and options sentiment is only mildly constructive. For an inpatient investor, this is not an attractive entry today.
Price closed at 61.65, slightly below the 61.79 reference, with the stock trading under its pivot at 63.07. The trend is bearish: SMA_200 > SMA_20 > SMA_5, which confirms downside structure. MACD histogram is negative at -0.0555 and still contracting, showing momentum weakness. RSI_6 at 45.68 is neutral, so there is no oversold buy signal. Support is near 59.73 and resistance at 66.41, meaning the stock is sitting closer to support than breakout territory, but the current setup is still not a clear bullish reversal.

["Q3 2026 financials showed strong growth: revenue up 37.76% YoY, net income up 128.12% YoY, and EPS up 116.67% YoY.", "Revenue and earnings acceleration indicate the core business is still expanding.", "Several analysts still maintain Buy/Overweight ratings despite reducing targets.", "Option positioning remains somewhat constructive with put-call open interest below 1."]
["Morgan Stanley downgraded ELF to Equal Weight and cut its target to $67 from $80, citing market share losses and pressure from smaller brands.", "A broad cluster of analysts have sharply lowered price targets over the past month, signaling weakening Street conviction.", "Insiders are selling, and selling increased 3611.29% over the last month.", "Hedge funds are neutral with no significant accumulation trend.", "News includes a fiduciary duty investigation by Halper Sadeh LLC, creating a governance overhang.", "Technical trend remains bearish with MACD negative and moving averages stacked bearishly.", "The stock is near but still below pivot resistance, not in a confirmed rebound.", "No AI Stock Picker or SwingMax signal is present today."]
Latest quarter shown is Q3 2026. Revenue rose to $489.5M, up 37.76% YoY, net income increased to $39.4M, up 128.12% YoY, and EPS rose to $0.65, up 116.67% YoY. Gross margin slipped slightly to 70.99%, down 0.42% YoY. Overall, the latest quarter was very strong on growth and profitability, with only a mild margin decline.
Analyst sentiment has turned more cautious. Morgan Stanley downgraded the stock to Equal Weight and cut its target to $67, while Baird, TD Cowen, JPMorgan, Citi, BofA, UBS, and Evercore all reduced targets recently. Some firms still keep Buy/Outperform ratings, but the overall trend is clearly toward lower price targets and more concern about market share pressure, margin risk, and softer forward outlook. Wall Street pros are still split, but the balance of opinion has become less favorable.